How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Addiction Treatment Market
- By Treatment Type: Detoxification, Behavioral Therapy, Medication-Assisted Treatment (MAT), Residential Rehabilitation, Outpatient Rehabilitation
- By Addiction Type: Alcohol Addiction, Opioid Addiction, Tobacco Addiction, Stimulant Addiction, Cannabis Addiction
- By Service Provider: Hospitals, Specialty Clinics, Rehabilitation Centers, Mental Health Facilities, Telehealth Services
- By End User: Adults, Adolescents, Veterans, Pregnant Women, Chronic Relapse Patients
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Detoxification leads By Treatment Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 281 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.170 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the Addiction Treatment Market report
A complete, evidence-based study - 11 chapters and 118 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Treatment Type 5
Addiction Type 5
Service Provider 5
End User 5
Companies profiled
Acadia Healthcare Company Inc.
Universal Health Services Inc.
Hazelden Betty Ford Foundation
American Addiction Centers Inc.
CRC Health Group (a division of Acadia Healthcare)
Promises Behavioral Health
The Recovery Village (part of Advanced Recovery Systems)
Elements Behavioral Health
Sierra Tucson
Caron Treatment Centers
The Meadows
Passages Malibu
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Acadia Healthcare Company Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Universal Health Services Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Hazelden Betty Ford Foundation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →American Addiction Centers Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →CRC Health Group (a division of Acadia Healthcare)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Promises Behavioral Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →The Recovery Village (part of Advanced Recovery Systems)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Elements Behavioral Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Sierra Tucson
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Caron Treatment Centers
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →The Meadows
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Passages Malibu
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Talbott Recovery
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Promises Treatment Centers
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Newport Academy
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,825M by 2033 · 7.8% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Detoxification62.6
- Behavioral Therapy9.2
- Medication-Assisted Treatment (MAT)8.9
- Residential Rehabilitation7.3
- Outpatient Rehabilitation12.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$512.0M → $1,008M · 8.8%
Europe$356.8M → $664.3M · 8.1%
Asia Pacific$325.8M → $658.0M · 9.2%
Latin America$201.7M → $379.6M · 8.2%
Middle East and Africa$155.1M → $251.3M · 6.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.732026
7.742027
7.762028
7.762029
7.792030
7.782031
7.802032
7.812033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Acadia Healthcare Company Inc.20.5
- Universal Health Services Inc.16.3
- Hazelden Betty Ford Foundation13.3
- American Addiction Centers Inc.6.2
- CRC Health Group (a division of Acadia Healthcare)10.1
- Promises Behavioral Health5.6
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Treatment Type25.7%
Addiction Type28.3%
Service Provider30.9%
End User15.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.0
- Europe22.4
- Asia Pacific22.2
- Latin America12.8
- Middle East and Africa8.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Acadia Healthcare Company Inc. | 89 | 77 | 83 | 95 | 97 | 85 | 88 |
| Universal Health Services Inc. | 70 | 75 | 78 | 80 | 68 | 70 | 74 |
| Hazelden Betty Ford Foundation | 74 | 77 | 65 | 66 | 69 | 75 | 71 |
| American Addiction Centers Inc. | 60 | 57 | 69 | 70 | 58 | 64 | 63 |
| CRC Health Group (a division of Acadia Healthcare) | 64 | 52 | 57 | 65 | 69 | 57 | 61 |
| Promises Behavioral Health | 64 | 52 | 55 | 69 | 48 | 62 | 58 |
| The Recovery Village (part of Advanced Recovery Systems) | 59 | 65 | 48 | 45 | 52 | 64 | 56 |
| Elements Behavioral Health | 38 | 42 | 50 | 56 | 44 | 49 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Acadia Healthcare Company Inc.
- Universal Health Services Inc.
- Hazelden Betty Ford Foundation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Acadia Healthcare Company Inc. | ◐ | ✓ | ◐ | ✓ | ✓ | ✓ |
| Universal Health Services Inc. | ◐ | − | ◐ | ✓ | ◐ | ◐ |
| Hazelden Betty Ford Foundation | − | ✓ | ◐ | − | ◐ | ✓ |
| American Addiction Centers Inc. | ◐ | − | ◐ | − | − | ◐ |
| CRC Health Group (a division of Acadia Healthcare) | ◐ | ◐ | − | ◐ | ✓ | − |
| Promises Behavioral Health | ✓ | − | ◐ | ◐ | − | ◐ |
| The Recovery Village (part of Advanced Recovery Systems) | ◐ | − | − | ◐ | ◐ | − |
| Elements Behavioral Health | ◐ | − | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Acadia Healthcare Company Inc.88
2Universal Health Services Inc.74
3Hazelden Betty Ford Foundation71
4American Addiction Centers Inc.63
5CRC Health Group (a division of Acadia Healthcare)61
6Promises Behavioral Health58
7The Recovery Village (part of Advanced Recovery Systems)56
8Elements Behavioral Health47
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Acadia Healthcare Company Inc.
Challenger2
Strong scale, closing on the leaders.
Universal Health Services Inc.Hazelden Betty Ford Foundation
Contender3
Focused players with pockets of strength.
American Addiction Centers Inc.CRC Health Group (a division of Acadia Healthcare)Promises Behavioral Health
Niche2
Specialists in a single segment or region.
The Recovery Village (part of Advanced Recovery Systems)Elements Behavioral Health
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Treatment Type in North America, then scale across Addiction Treatment Market — a $40M beachhead inside a $728M market.
Beachhead (SOM)$40Mobtainable near-term
Serviceable (SAM)$275Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Detoxification
Best fit — highest urgency & budget in Treatment Type.
Economic buyer79 fit
Behavioral Therapy
Strong fit — clear ROI and a fast path to value.
End user69 fit
Medication-Assisted Treatment (MAT)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Treatment Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Addiction Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Service Provider
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel27%
Digital / self-serve19%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Treatment Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Addiction Treatment Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified24%
Evaluation14%
Closed-won8%
$21.4KCAC
$91KLTV
4.3:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Addiction Treatment Market is a resilient opportunity — $4.05B by 2033, compounding at 4.7%.
TAM · 2025$2.80Btoday
TAM · 2033$4.05Bforecast
CAGR4.7%2027–2033
Cumulative$30.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.05BTotal addressable market
SAM$1.67BServiceable available market
SOM$330MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.7% CAGR
Demand compounds through 2033, outpacing GDP across Treatment Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Treatment Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.05BLarge & growingTAM by 2033 at 4.7% CAGR
$1.67BServiceable nowreachable with today’s model
$330MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.16BBear3.1% CAGR
$4.05BBase4.7% CAGR
$5.18BBull6.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Addiction Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Addiction Treatment Market — a $3.98B market by 2033. Plan: grow share from 7.9% to 12.3%.
Market size · 2033$3.98Btotal addressable
Market CAGR5.7%2027–2033
Target share12.3%from 7.9% today
Revenue ambition$490Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.9% | 12.3% | Behind |
| Revenue | $305M | $490M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | At risk |
| Gross margin | 32.3% | 43.0% | Behind |
| Customer retention | 84.3% | 92.8% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Treatment Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Addiction Type capability
A defensible second engine — invest in Addiction Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Treatment Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Addiction Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $55M capacity & capability investment
- Greenlight bolt-on M&A in Addiction Type
- Authorise North America expansion plan
- Fund R&D program for Treatment Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAt risk
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Addiction Treatment Market conversation — a $3.02B market you can size, segment and defend in minutes.
Market size · 2033$3.02Btotal opportunity
Growth4.9%CAGR to 2033
Addressable buyers1,015+accounts in scope
Typical ROI4.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Treatment Type
Goal Grow share in Treatment Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.2×return on cost, year one
< 4 mopayback period
$66K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Acadia Healthcare Company Inc.Universal Health Services Inc.Hazelden Betty Ford FoundationAmerican Addiction Centers Inc.CRC Health Group (a division of Acadia Healthcare)Promises Behavioral HealthThe Recovery Village (part of Advanced Recovery Systems)Elements Behavioral Health+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Addiction Treatment Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Addiction Treatment Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →ADC Drug Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportWeb-based Recruitment Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportAdaptive Switches Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportAdaptive Strollers for Special Needs Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportAdaptive Servo-Ventilators (ASV) Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportAdaptive Lenses Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportWaiver Software Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportAdaptable Alternating Pressure Systems Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportAdapalene Products Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportAdapalene Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportAdapalene Gel Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportAdapalene Benzoyl Peroxide Gel Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.